Status:
ACTIVE_NOT_RECRUITING
Edwards EVOQUE Eos MISCEND Study
Lead Sponsor:
Edwards Lifesciences
Conditions:
Mitral Valve Regurgitation (Degenerative or Functional)
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Study to evaluate the safety and performance of the Edwards EVOQUE Eos mitral valve replacement system
Detailed Description
The study is a multi-center, prospective, single-arm, and non-randomized study designed to evaluate the safety and performance of the Edwards EVOQUE Eos mitral valve replacement system.
Eligibility Criteria
Inclusion
- Clinically significant, symptomatic mitral regurgitation
- High risk for open-heart surgery
- Meets anatomical criteria
Exclusion
- Unsuitable anatomy
- Patient is inoperable
Key Trial Info
Start Date :
February 6 2015
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 30 2033
Estimated Enrollment :
123 Patients enrolled
Trial Details
Trial ID
NCT02718001
Start Date
February 6 2015
End Date
April 30 2033
Last Update
November 27 2024
Active Locations (19)
Enter a location and click search to find clinical trials sorted by distance.
1
Sutter Mills-Peninsula
Burlingame, California, United States, 94010
2
Cedars-Sinai Medical Center
Los Angeles, California, United States, 90048
3
Kaiser Permanente San Francisco
San Francisco, California, United States, 94118
4
Emory University Hospital/Emory University Hospital Midtown
Atlanta, Georgia, United States, 30322